文献速递传染病防控与疫情报告免疫规划

津巴布韦儿童和年轻成人中伤寒结合疫苗应对疫情的效果:一项配对病例对照研究

Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study.
PubMed 文献 · Vaccine · 2022-06-09

在津巴布韦哈拉雷三个城市郊区开展配对病例对照研究,评估伤寒结合疫苗(TCV)针对培养确诊伤寒沙门菌的效果。6个月至15岁儿童调整后疫苗效果为75%(95%CI:1-94,p=0.049,对照为 facility 对照)和84%(95%CI:57-94,p<0.001,对照为社区对照);6个月至45岁人群为46%(95%CI:26-77,p=0.153)和67%(95%CI:35-83,p=0.002)。研究确认一剂TCV在非洲环境下对6个月至15岁儿童控制伤寒有效。

要点

  • 6个月至15岁儿童中,一剂TCV调整后疫苗效果为75%(95%CI:1-94,p=0.049,对照为 facility 对照)和84%(95%CI:57-94,p<0.001,对照为社区对照)。
  • 6个月至45岁人群中,调整后疫苗效果为46%(95%CI:26-77,p=0.153,对照为 facility 对照)和67%(95%CI:35-83,p=0.002,对照为社区对照)。
  • 研究确认一剂TCV在非洲环境下对6个月至15岁儿童控制伤寒有效。

核心结论

  • 本研究确认一剂TCV在非洲环境下对6个月至15岁儿童控制伤寒有效。

研究设计与样本

  • 在哈拉雷三个城市郊区开展配对病例对照研究,这些郊区是TCV疫苗接种活动的目标区域。
  • 疑似伤寒病例在四家卫生机构前瞻性入组,并按机构(1:1)和社区(1:5)匹配对照。
  • 2019年7月至2020年3月共纳入504例疑似病例,其中148例实验室确诊伤寒病例和153例确认为阴性的对照。

主要发现

  • 105例病例(其中47例年龄为6个月至15岁)按年龄、性别和居住地与105例机构对照匹配;96例病例按年龄、性别和近邻与229例社区对照以1:5匹配。
  • 6个月至15岁儿童中,针对确诊伤寒的调整后疫苗效果与机构对照相比为75%(95%CI:1-94,p=0.049),与社区对照相比为84%(95%CI:57-94,p<0.001)。
  • 6个月至45岁人群中,针对确诊伤寒的调整后疫苗效果与机构对照相比为46%(95%CI:26-77,p=0.153),与社区对照相比为67%(95%CI:35-83,p=0.002)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Zimbabwe suffers from regular outbreaks of typhoid fever (TF), worse since 2017. Most cases were in Harare and a vaccination campaign with Typhoid Conjugate Vaccine (TCV) was conducted in March 2019. The vaccine effectiveness (VE) was assessed against culture-confirmed S. Typhi in children six months to 15 years and in individuals six months to 45 years in Harare. METHODS: A matched case-control study was conducted in three urban suburbs of Harare targeted by the TCV vaccination campaign. Suspected TF cases were enrolled prospectively in four health facilities and were matched to facility (1:1) and community (1:5) controls. FINDINGS: Of 504 suspected cases from July 2019 to March 2020, 148 laboratory-confirmed TF cases and 153 controls confirmed-negative were identified. One hundred and five (47 aged six months to 15 years) cases were age, sex, and residence matched with 105 facility-based controls while 96 cases were matched 1:5 by age, sex, and immediate-neighbour with 229 community controls. The adjusted VE against confirmed TF was 75% (95%CI: 1-94, p = 0.049) compared to facility controls, and 84% (95%CI: 57-94, p < 0.001) compared to community controls in individuals six months to 15 years. The adjusted VE against confirmed TF was 46% (95%CI: 26-77, p = 0.153) compared to facility controls, and 67% (95%CI: 35-83, p = 0.002) compared to community controls six months to 45 years old. INTERPRETATION: This study confirms that one vaccine dose of TCV is effective to control TF in children between six months and 15 years old in an African setting.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lightowler MS, Manangazira P, Nackers F, et al. Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study. Vaccine. 2022. PMID: 35690501. doi:10.1016/j.vaccine.2022.04.093

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。